Effects of Omega-3 Fatty Acids on Muscle Mass, Muscle Strength and Muscle Performance among the Elderly: A Meta-Analysis
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
There is increasing evidence showing the role of fatty acids and their derived lipid intermediates in the regulation of skeletal muscle mass synthesis and function. However, the role of omega-3 fatty acids remains unclear. Therefore, we conducted a meta-analysis to evaluate the potential effects of omega-3 fatty acids on sarcopenia-related performances among the elderly. Eligible literature and reports of randomized controlled trials were comprehensively searched from the PubMed, Cochrane Library, ClinicalTrials.gov, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases until July 2018. A total of 10 articles were available for the meta-analysis. There were minor benefits for muscle mass gain (0.33 kg; 95% CI: 0.05, 0.62) and timed up and go performance (−0.30 s; 95% CI: −0.43, −0.17). Subgroup analyses regarding muscle mass and walk speed indicated that omega-3 fatty acid supplements at more than 2 g/day may contribute to muscle mass gain (0.67 kg; 95% CI: 0.16, 1.18) and improve walking speed, especially for those receiving more than 6 months of intervention (1.78 m/sec; 95% CI: 1.38, 2.17). Our findings provide some insight into the effects of omega-3 fatty acids on muscle mass, especially for those taking supplements at more than 2 g/day. We also observed that a long period of omega-3 fatty acids supplementation may improve walking speed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In mice, acute administration raised circulating GLP-1 and insulin, improving glucose tolerance, an effect abrogated by a GLP-1 receptor antagonist (exendin-9), indicating an incretin-mediated hypoglycemic action [193].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In mice, acute administration raised circulating GLP-1 and insulin, improving glucose tolerance, an effect abrogated by a GLP-1 receptor antagonist (exendin-9), indicating an incretin-mediated hypoglycemic action [193].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
Experimental — accuracy not yet measuredIn the citing paper
“Taken together, evidence indicates that bitter melon could enhance the weight loss and glycemic benefits of GLP-1RAs by increasing endogenous GLP-1 and by improving metabolic profiles [193,194,198,199].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
In the citing paper
“In in vitro studies using the enteroendocrine cell line (STC-1), bitter melon extracts dosedependently increase GLP-1 release, an effect partially blocked by a bitter taste receptor antagonist (probenecid) and by a phospholipase Cβ2 inhibitor (U-73122), suggesting a taste receptor-mediated mechanism [193].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
In the citing paper
“In in vitro studies using the enteroendocrine cell line (STC-1), bitter melon extracts dosedependently increase GLP-1 release, an effect partially blocked by a bitter taste receptor antagonist (probenecid) and by a phospholipase Cβ2 inhibitor (U-73122), suggesting a taste receptor-mediated mechanism [193].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817 · cited 1×
“The methodological quality of included studies was evaluated according to the Cochrane Collaboration risk-of-bias tool [28].”
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164 · cited 1×
“This systematic review and meta-analysis was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [27].”
MethodSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 1×
“The recently updated consensus EWGSOP guideline for the case-finding and diagnosis of sarcopenia (EWGSOP2) focused on low muscle strength (and not low muscle mass) as a principal feature of sarcopenia [45].”
BackgroundSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 2×
“The original definition of sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP) was the “presence of both low muscle mass + low muscle function (strength or performance)” [3].”
BackgroundMethodGRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Meaningful change and responsiveness in common physical performance measures in older adults.
Perera, S., Mody, S. H., Woodman, R. C., & Studenski, S. A. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00701.x · Cited by 2,513 · cited 1×
“This change is clinically relevant in the context of aging [49].”
BackgroundDisability in Older Adults: Evidence Regarding Significance, Etiology, and Risk
Fried, L. P., & Guralnik, J. M. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb00986.x · Cited by 866
Smith, G. I., Atherton, P., Reeds, D. N., Mohammed, B. S., Rankin, D., Rennie, M. J., & Mittendorfer, B. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005611 · Cited by 665 · cited 4×
“An association between n-3 PUFAs intake and musculoskeletal health has also been reported in RCTs [18,19], which showed that supplementation with n-3 PUFAs enhanced the rate of muscle protein synthesis in the elderly; in a strength-training trial [20], fish-oil supplementation resulted in significantly improved muscle…”
ResultInfluentialOmega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub3 · Cited by 630
DIETARY n-6 AND n-3 FATTY ACID BALANCE AND CARDIOVASCULAR HEALTH
Wijendran, V., & Hayes, K. C. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132106 · Cited by 609 · cited 1×
“In healthy adults, only 5–10% and 2–5% of ALA can be converted into EPA and DHA, respectively [24].”
BackgroundNutrition and physical activity in the prevention and treatment of sarcopenia: systematic review.
the IOF-ESCEO Sarcopenia Working Group, Beaudart, C., Dawson, A., Shaw, S. C., Harvey, N. C., Kanis, J. A., Binkley, N., Reginster, J. Y., Chapurlat, R., Chan, D. C., et al. (2017) · Osteoporosis International · doi:10.1007/s00198-017-3980-9 · Cited by 602 · cited 2×
“Physical exercise a d nutritional supplementation are currently recomm nded s pr ventive measures ag inst the loss of muscle m ss, muscle strength, or p ysical perform nce [7].”
BackgroundFish oil–derived n−3 PUFA therapy increases muscle mass and function in healthy older adults
Smith, G. I., Julliand, S., Reeds, D. N., Sinacore, D. R., Klein, S., & Mittendorfer, B. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.105833 · Cited by 507 · cited 3×
“5 g of DHA or fatty fish consumption, for muscle mass, muscle strength, and physical function in older people [21,22].”
BackgroundSluijs, I., Beulens, J. W. J., van der A, D. L., Spijkerman, A. M. W., Grobbee, D. E., & van der Schouw, Y. T. (2010) · Diabetes Care · doi:10.2337/dc09-1321 · Cited by 335
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., Summerbell, C. D., Worthington, H. V., Song, F., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub5 · Cited by 295
Murphy, R. A., Mourtzakis, M., Chu, Q. S. C., Baracos, V. E., Reiman, T., & Mazurak, V. C. (2011) · Cancer · doi:10.1002/cncr.25709 · Cited by 288 · cited 4×
“As for n-3 PUFA sources, there is a report of a strong association between EPA supplementation, increased plasma EPA levels, and elicited gains in the muscle mass of patients with non-small cell lung cancer [37].”
BackgroundInfluentialRobinson, S. M., Jameson, K. A., Batelaan, S. F., Martin, H. J., Syddall, H. E., Dennison, E. M., Cooper, C., Sayer, A. A., & the Hertfordshire Cohort Study Group (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01478.x · Cited by 282
The health economics burden of sarcopenia: a systematic review
Bruyère, O., Beaudart, C., Ethgen, O., Reginster, J.-Y., & Locquet, M. (2019) · Maturitas · doi:10.1016/j.maturitas.2018.11.003 · Cited by 275 · cited 1×
“Furthermore, people with sarcopenia need substantially more medical care and incur more health-related costs [6].”
BackgroundFish-oil supplementation enhances the effects of strength training in elderly women
Rodacki, C. L., Rodacki, A. L., Pereira, G., Naliwaiko, K., Coelho, I., Pequito, D., & Fernandes, L. C. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.021915 · Cited by 274 · cited 4×
“An association between n-3 PUFAs intake and musculoskeletal health has also been reported in RCTs [18,19], which showed that supplementation with n-3 PUFAs enhanced the rate of muscle protein synthesis in the elderly; in a strength-training trial [20], fish-oil supplementation resulted in significantly improved muscle…”
BackgroundResultInfluentialDefining Sarcopenia in Terms of Incident Adverse Outcomes
Woo, J., Leung, J., & Morley, J. E. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.11.013 · Cited by 261
Diet Quality and Sarcopenia in Older Adults: A Systematic Review
Bloom, I., Shand, C., Cooper, C., Robinson, S., & Baird, J. (2018) · Nutrients · doi:10.3390/nu10030308 · Cited by 244
Verreijen, A. M., Verlaan, S., Engberink, M. F., Swinkels, S., de Vogel-van den Bosch, J., & Weijs, P. J. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.090290 · Cited by 237
Whitehouse, A., Smith, H. J., Drake, J. L., & Tisdale, M. J. (2001) · PubMed · Cited by 226
Traylor, D. A., Gorissen, S. H. M., & Phillips, S. M. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy003 · Cited by 225
The role of omega-3 in the prevention and treatment of sarcopenia
Dupont, J., Dedeyne, L., Dalle, S., Koppo, K., & Gielen, E. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01146-1 · Cited by 203 · cited 4×
“Given that sarcopenia is associated with increased inflammatory responses and impaired glucose homeostasis, recent research suggests that n-3 PUFAs have anti-inflam atory properties, which may be exploited for the prevention or treatment of sarcopenia [16].”
BackgroundResultInfluentialGingras, A., White, P. J., Chouinard, P. Y., Julien, P., Davis, T. A., Dombrowski, L., Couture, Y., Dubreuil, P., Myre, A., Bergeron, K., et al. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.121079 · Cited by 193 · cited 1×
“Concordantly, both animal [43] and human [19,40] studies have shown that n-3 PUFA supplementation enhances amino acid- and insulin-mediated increases in the rates of muscle protein syntheses.”
Da Boit, M., Sibson, R., Sivasubramaniam, S., Meakin, J. R., Greig, C. A., Aspden, R. M., Thies, F., Jeromson, S., Hamilton, D. L., Speakman, J. R., et al. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.140780 · Cited by 185 · cited 2×
“Apart from the two RCTs mentioned above [32,38] with diet intervention, only three [20,31,36] of the remaining 10 RCTs requested that the study participants maintain their habitual diet.”
BackgroundRisk factors for incident falls in older men and women: the English longitudinal study of ageing
Galé, C. R., Westbury, L. D., Cooper, C. C., & Dennison, E. M. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0806-3 · Cited by 166
Logan, S. L., & Spriet, L. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144828 · Cited by 155 · cited 2×
“Apart from the two RCTs mentioned above [32,38] with diet intervention, only three [20,31,36] of the remaining 10 RCTs requested that the study participants maintain their habitual diet.”
BackgroundHutchins-Wiese, H., Kleppinger, A., Annis, K., Liva, E., Lammi‐Keefe, C. J., Durham, H. A., & Kenny, R. A. (2012) · The journal of nutrition health & aging · doi:10.1007/s12603-012-0415-3 · Cited by 153 · cited 2×
“(2013) [34] USA 75 Postmenopausal women (126) 100 24 NA EPA:0.”
ResultYou, J.-S., Mcnally, R. M., Jacobs, B. L., Privett, R. E., Gundermann, D. M., Lin, K.-H., Steinert, N. D., Goodman, C. A., & Hornberger, T. A. (2019) · The FASEB Journal · doi:10.1096/fj.201801653rr · Cited by 149 · cited 1×
“Several muscle synthesis mechanisms involving n-3 PUFAs have been proposed, including the induction of the mTORC1-p70S6K1 signaling pathway, which leads to increased protein synthesis [41] and the downregulation of proteasome expression, thus suppressing muscle protein catabolism [42].”
BackgroundLalia, A. Z., Dasari, S., Robinson, M. M., Abid, H., Morse, D. M., Klaus, K. A., & Lanza, I. R. (2017) · Aging · doi:10.18632/aging.101210 · Cited by 140 · cited 2×
“An association between n-3 PUFAs intake and musculoskeletal health has also been reported in RCTs [18,19], which showed that supplementation with n-3 PUFAs enhanced the rate of muscle protein synthesis in the elderly; in a strength-training trial [20], fish-oil supplementation resulted in significantly improved muscle…”
ResultTessier, A.-J., & Chevalier, S. (2018) · Nutrients · doi:10.3390/nu10081099 · Cited by 132 · cited 2×
“Even though studies had discussed n-3 PUFAs, outcomes with strong evidence or clear conclusions wer seldom pres nted [15,16].”
ResultTinker, L. F., Sarto, G. E., Howard, B. V., Huang, Y., Neuhouser, M. L., Mossavar-Rahmani, Y., Beasley, J. M., Margolis, K. L., Eaton, C. B., Phillips, L. S., et al. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.018648 · Cited by 122
Self-citationCangussu, L. M., Nahás-Neto, J., Orsatti, C. L., Bueloni-Dias, F. N., & Nahás, E. A. P. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3151-9 · Cited by 114
Alpha-linolenic acid supplementation and resistance training in older adults
Cornish, S. M., & Chilibeck, P. D. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-136 · Cited by 112 · cited 4×
“A study [25] showed that ALA decreases the levels of plasma inflammatory cytokines, such as tumor necrosis factor (TNF)-alpha and interleukin (IL)-6, which may further improve muscle mass and strength in the elderly.”
BackgroundInfluentialKrzymińska-Siemaszko, R., Czepulis, N., Lewandowicz, M., Zasadzka, E., Suwalska, A., Witowski, J., & Wieczorowska–Tobis, K. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120910558 · Cited by 112 · cited 5×
“There was no significant difference in the muscle mass between the n-3 PUFA group and the control group in both 61 females [25,35,38] and 14 males [25].”
BackgroundMethodResultInfluentialStrandberg, E., Edholm, P., Ponsot, E., Wåhlin‐Larsson, B., Hellmén, E., Nilsson, A. E., Engfeldt, P., Cederholm, T., Risérus, U., & Kadi, F. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00066.2015 · Cited by 99
Strike, S., Carlisle, A., Gibson, E. L., & Dyall, S. C. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv109 · Cited by 96 · cited 1×
“Consistent with our findings, the three-city study showed that higher plasma concentrations of long-chain n-3 PUFAs were associated with a lower proportion of individuals with slow gait speed [48], but only among the elders receiving at least 6-month of n-3 PUFA supplementation in subgroups from two studies [34,39].”
ResultRousseau, J. H., Kleppinger, A., & Kenny, A. M. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01870.x · Cited by 88 · cited 1×
“Fish intake related to muscle strength in observational studies are not consistent [22,46].”
BackgroundGrenon, S. M., Owens, C. D., Nosova, E. V., Hughes‐Fulford, M., Alley, H. F., Chong, K. C., Perez, S., Yen, P. K., Boscardin, W. J., Hellmann, J. L., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002034 · Cited by 87 · cited 1×
“[33] were not considered for meta-analysis due to the lack of numerical data for the functional outcomes in the former and the reporting of only patient-perceived walking performance in the latter.”
BackgroundFish oil-derived n-3 polyunsaturated fatty acids for the prevention and treatment of sarcopenia
Gray, S. R., & Mittendorfer, B. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000441 · Cited by 83
ter Borg, S., Luiking, Y. C., van Helvoort, A., Boirie, Y., Schols, J. M. G. A., & de Groot, C. P. G. M. (2018) · The journal of nutrition health & aging · doi:10.1007/s12603-018-1108-3 · Cited by 82 · cited 1×
“This is consistent with evidence that lower EPA levels are associated with lower muscle mass, strength and function [44].”
Rolland, Y., Barreto, P. D. S., Maltais, M. L., Guyonnet, S., Cantet, C., Andrieu, S., & Vellas, B. J. (2019) · Nutrients · doi:10.3390/nu11081931 · Cited by 69 · cited 2×
“8 g of DHA) supplementation had no effect on muscle strength in elderly people [23].”
BackgroundWang, E. T., de Koning, L., & Kanaya, A. M. (2010) · Journal of the American College of Nutrition · doi:10.1080/07315724.2010.10719826 · Cited by 63
Edholm, P., Strandberg, E., & Kadi, F. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00924.2016 · Cited by 54
Rodríguez‐Cruz, M., Cruz‐Guzmán, O. D. R., Almeida‐Becerril, T., Solís-Serna, A. D., Atilano-Miguel, S., Sánchez-González, J. R., Barbosa-Cortés, L., Ruíz-Cruz, E. D., Huicochea, J. C., Cárdenas‐Conejo, A., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.09.011 · Cited by 50 · cited 2×
“Concordantly, both animal [43] and human [19,40] studies have shown that n-3 PUFA supplementation enhances amino acid- and insulin-mediated increases in the rates of muscle protein syntheses.”
ResultFrison, É., Boirie, Y., Peuchant, E., Tabué-Teguo, M., Barberger‐Gateau, P., & Féart, C. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.12.008 · Cited by 41 · cited 1×
“Consistent with our findings, the three-city study showed that higher plasma concentrations of long-chain n-3 PUFAs were associated with a lower proportion of individuals with slow gait speed [48], but only among the elders receiving at least 6-month of n-3 PUFA supplementation in subgroups from two studies [34,39].”
ResultLee, S.-R., Jo, E., & Khamoui, A. V. (2019) · Sports · doi:10.3390/sports7070167 · Cited by 20
Cited by
Bird, J. K., Troesch, B., Warnke, I., & Calder, P. C. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.10.011 · Cited by 107
“Another meta-analysis using studies performed in elderly subjects identified that omega-3 LC PUFA supplements increased muscle mass, whereas grip strength was not affected [122].”
BackgroundResultAge-related muscle anabolic resistance: inevitable or preventable?
Aragon, A. A., Tipton, K. D., & Schoenfeld, B. J. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuac062 · Cited by 93
Cornish, S. M., Cordingley, D. M., Shaw, K. A., Forbes, S. C., Leonhardt, T., Bristol, A., Candow, D. G., & Chilibeck, P. D. (2022) · Nutrients · doi:10.3390/nu14112221 · Cited by 79
Advances in nutritional supplementation for sarcopenia management
Liu, S., Zhang, L., & Li, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1189522 · Cited by 75
The Effect of Omega-3 Fatty Acids on Sarcopenia: Mechanism of Action and Potential Efficacy
Therdyothin, A., Phiphopthatsanee, N., & Isanejad, M. (2023) · Marine Drugs · doi:10.3390/md21070399 · Cited by 93
“30 s respectively [46,59], although the latter was limited by the small number of pooled participants of only 73 receiving n-3 PUFA and 63 controls.”
BackgroundMethodInfluential
Metadata
- Authors
- Huang, Y.-H., Chiu, W.-C., Hsu, Y.-P., Lo, Y.-L., & Wang, Y.-H.
- Affiliations
- Taipei City Hospital (TW)
- Taipei Medical University (TW)
- Wan Fang Hospital (TW)
- National Yang Ming University (TW)
- Taipei Medical University-Shuang Ho Hospital (TW)
- Corresponding author
- Wang, Yuan-Hung
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-12-04
- Volume
- 12
- Issue
- 12
- Pages
- 3739
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7761957
- OpenAlex
- W3108657423
- Cited by
- 142
- References
- 50
- Citations by year
- 2026: 21 · 2025: 40 · 2024: 29 · 2023: 23 · 2022: 16 · 2021: 13
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- omega-3 fatty acids, dietary supplementation, sarcopenia, muscle mass, muscle strength, muscle performance, older adults, Timed Up and Go test, walking speed
- MeSH terms
- Physical Functional Performance, Aged, Diet, Docosahexaenoic Acids, Female, Gait, Humans, Male, Middle Aged, Eicosapentaenoic Acid, Fatty Acids, Omega-3, Randomized Controlled Trials as Topic, Muscle, Skeletal, Dietary Supplements, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.